Differential Responses to IFN-α Subtypes in Human T Cells and Dendritic Cells 12
暂无分享,去创建一个
[1] B. Williams,et al. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .
[2] C. Biron. Interferons α and β as Immune Regulators—A New Look , 2001 .
[3] Jakob S. Jensen,et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.
[4] J. O’Shea,et al. Inducible Expression of Stat4 in Dendritic Cells and Macrophages and Its Critical Role in Innate and Adaptive Immune Responses1 , 2001, The Journal of Immunology.
[5] J U Gutterman,et al. Cytokine therapeutics: lessons from interferon alpha. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] Y Oikawa,et al. Elevated serum IP-10 levels observed in type 1 diabetes. , 2001, Diabetes care.
[7] H. Thomas,et al. Different relative activities of human cell-derived interferon-alpha subtypes: IFN-alpha 8 has very high antiviral potency. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[8] P. Sehgal. The interferon genes. , 1982, Biochimica et biophysica acta.
[9] W. Yeow,et al. Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. , 1998, Journal of immunology.
[10] S. Pestka,et al. Specific molecular activities of recombinant and hybrid leukocyte interferons. , 1982, The Journal of biological chemistry.
[11] L. Rogge,et al. Regulation of the IL‐12/IL‐12R axis: a critical step in T‐helper cell differentiation and effector function , 1999, Immunological reviews.
[12] A. Lukashin,et al. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[13] K. Zoon,et al. Purification and characterization of multiple components of human lymphoblastoid interferon-alpha. , 1992, The Journal of biological chemistry.
[14] P. A. Tilbrook,et al. Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. , 2003, Blood.
[15] E. Bosi,et al. Fulminant autoimmune Type 1 diabetes during interferon‐alpha therapy: a case of Th1‐mediated disease? , 2001, Diabetic medicine : a journal of the British Diabetic Association.
[16] S. Nagata,et al. Different binding of human interferon alpha 1 and alpha 2 to common receptors on human and bovine cells. Studies with recombination interferons produced in Escherichia coli. , 1983, The Journal of biological chemistry.
[17] C. Griffiths,et al. PSORIASIS AND INTERFERON , 1986, The Lancet.
[18] L. Pfeffer,et al. Interferon α/β Promotes Cell Survival by Activating Nuclear Factor κB through Phosphatidylinositol 3-Kinase and Akt* , 2001, The Journal of Biological Chemistry.
[19] S. Gupta,et al. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. , 1999, Journal of immunology.
[20] G. Stark,et al. Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways. , 1993, The EMBO journal.
[21] J. de Maeyer-Guignard,et al. Type I interferons. , 1998, International reviews of immunology.
[22] E. Coccia,et al. IFN-αβ Released by Mycobacterium tuberculosis-Infected Human Dendritic Cells Induces the Expression of CXCL10: Selective Recruitment of NK and Activated T Cells 1 , 2003, The Journal of Immunology.
[23] F. Belardelli,et al. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.
[24] S. Harroch,et al. Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN‐alpha and IFN‐beta. , 1994, The EMBO journal.
[25] Y. Ohmori,et al. The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. , 1995, Journal of immunology.
[26] M. Dziejman,et al. IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1 , 2002, The Journal of Immunology.
[27] B. Williams,et al. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons , 1999, The EMBO journal.
[28] E. Fish,et al. Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells. , 1983, Biochemical and biophysical research communications.
[29] H. Keirstead,et al. Neutralization of the Chemokine CXCL10 Reduces Inflammatory Cell Invasion and Demyelination and Improves Neurological Function in a Viral Model of Multiple Sclerosis1 , 2001, The Journal of Immunology.
[30] J. Farrar,et al. Type I interferons and T helper development. , 2000, Immunology today.
[31] T. Taniguchi,et al. A weak signal for strong responses: interferon-alpha/beta revisited , 2001, Nature Reviews Molecular Cell Biology.
[32] J. Schwartzman,et al. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. , 2000, Immunity.
[33] D. Näf,et al. Different pathways mediate virus inducibility of the human IFN-α1 and IFN-β genes , 1990, Cell.
[34] D. Cantrell,et al. IL‐12 selectively regulates STAT4 via phosphatidylinositol 3‐kinase and Ras‐independent signal transduction pathways , 2000, European journal of immunology.
[35] R. Rees,et al. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. , 1996, Journal of Immunology.
[36] D. Levy,et al. Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7 , 1998, The EMBO journal.
[37] J. Platt,et al. Transplantation of discordant xenografts: a challenge revisited. , 1996, Immunology today.
[38] G. Foster,et al. Human type I interferons differ greatly in their effects on the proliferation of primary B cells. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[39] G. Stark,et al. Requirement of Phosphoinositide 3-Kinase and Akt for Interferon-β-mediated Induction of the β-R1(SCYB11) Gene* , 2002, The Journal of Biological Chemistry.
[40] K. Cantell,et al. Differential expression of human interferon genes. , 1984, Nucleic acids research.
[41] N. Roberts,et al. Different antiviral spectra of human macrophage interferon activities , 1983, Nature.
[42] J. Galon,et al. Stat4 Is Expressed in Activated Peripheral Blood Monocytes, Dendritic Cells, and Macrophages at Sites of Th1-Mediated Inflammation1 , 2000, The Journal of Immunology.
[43] H. Weiner,et al. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] K. Öberg,et al. Autoimmune Phenomena in Patients with Malignant Carcinoid Tumors During Interferon-α Treatment , 1991 .
[45] K. Zoon,et al. Evidence for multiple binding sites for several components of human lymphoblastoid interferon-alpha. , 1993, The Journal of biological chemistry.
[46] L. Platanias,et al. Differential Use of the βL Subunit of the Type I Interferon (IFN) Receptor Determines Signaling Specificity for IFNα2 and IFNβ* , 1998, The Journal of Biological Chemistry.
[47] P. Koskinen,et al. Interferon- Activates Multiple STAT Proteins and Upregulates Proliferation-Associated IL-2R, c-myc, and pim-1 Genes in Human T Cells , 1999 .
[48] Sagie Schif-Zuck,et al. Targeting the Function of IFN-γ-Inducible Protein 10 Suppresses Ongoing Adjuvant Arthritis1 , 2002, The Journal of Immunology.
[49] Fritz Aberger,et al. Cell-type and Donor-specific Transcriptional Responses to Interferon-α , 2002, The Journal of Biological Chemistry.
[50] G. Uzé,et al. Shared receptor components but distinct complexes for alpha and beta interferons. , 1998, Journal of molecular biology.
[51] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[52] B. Cohen,et al. The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.
[53] E. Petricoin,et al. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. , 1995, Science.
[54] K. Simon,et al. Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] P. Lebon,et al. Constitutive expression of specific interferon isotypes in peripheral blood leukocytes from normal individuals and in promonocytic U937 cells , 1996, Journal of leukocyte biology.
[56] P. Moore,et al. Virus-specific Activation of a Novel Interferon Regulatory Factor, IRF-5, Results in the Induction of Distinct Interferon α Genes* , 2001, The Journal of Biological Chemistry.
[57] G. Uzé,et al. Shared receptor components but distinct complexes for α and β interferons 1 1Edited by M. Yaniv , 1998 .
[58] S. Akira,et al. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. , 1996, Journal of immunology.
[59] R. Herberman. Effect of α-interferons on immune function , 1997 .
[60] A. Gottlieb,et al. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques , 1988, The Journal of experimental medicine.
[61] G. Lutfalla,et al. Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA , 1990, Cell.
[62] L. Platanias,et al. The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. , 2000, The Journal of biological chemistry.
[63] D. Patel,et al. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. , 2001, Clinical immunology.
[64] A. Sing,et al. Bacterial Induction of Beta Interferon in Mice Is a Function of the Lipopolysaccharide Component , 2000, Infection and Immunity.
[65] G. Stark,et al. Mutant U5A cells are complemented by an interferon‐alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. , 1995, The EMBO journal.
[66] Andrew D. Luster,et al. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.
[67] C. Bogdan,et al. Type 1 Interferon (IFNα/β) and Type 2 Nitric Oxide Synthase Regulate the Innate Immune Response to a Protozoan Parasite , 1998 .
[68] L. Platanias,et al. Activation of the p 38 Mitogen-activated Protein Kinase by Type I Interferons , 1999 .
[69] G. Foster,et al. Are all Type I human interferons equivalent? , 1998, Journal of viral hepatitis.
[70] J. Hiscott,et al. Selective DNA Binding and Association with the CREB Binding Protein Coactivator Contribute to Differential Activation of Alpha/Beta Interferon Genes by Interferon Regulatory Factors 3 and 7 , 2000, Molecular and Cellular Biology.
[71] S. Nagata,et al. Target cell specificity of two species of human interferon-alpha produced in Escherichia coli and of hybrid molecules derived from them. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[72] S. Pestka. The human interferon-alpha species and hybrid proteins. , 1997, Seminars in oncology.
[73] L. Platanias,et al. Differences in interferon alpha and beta signaling. Interferon beta selectively induces the interaction of the alpha and betaL subunits of the type I interferon receptor. , 1996, The Journal of biological chemistry.
[74] F. Belardelli,et al. The neglected role of type I interferon in the T-cell response: implications for its clinical use. , 1996, Immunology today.